Search
Results: 2
A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease
MK Hayer,
NC Edwards,
G Slinn,
WE Moody,
RP Steeds,
CJ Ferro,
AM Price,
C Andujar,
M Dutton,
R Webster,
DJ Webb,
S Semple,
I MacIntyre,
V Melville,
IB Wilkinson,
TF Hiemstra,
DC Wheeler,
A Herrey,
M Grant,
S Mehta,
N Ives,
JN Townend
Aug 31, 2017